Product Information
BLISOVI FE 1.5-30 TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1382 per EA under NDC 68180086913. Its NADAC has been published 42 times since Nov 5, 2025.
FDA first approved this application on Nov 18, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180086913
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA201585FDA Approved
11/18/2015
TE Code
AB
On Market Since
8/13/2025
Price Statistics
The NADAC for BLISOVI FE 1.5-30 TABLET has been published 42 times since Nov 5, 2025, and over the history we have for it it has declined 12.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1382 per EA |
|---|---|
| All-time high | $0.1575 (Nov 12, 2025) |
| All-time low | $0.1303 (Feb 18, 2026) |
| 52-week high | $0.1575 |
| 52-week low | $0.1303 |
| Median price | $0.1412 |
| Average price | $0.1419 |
| Largest weekly change | -5.5% (Jan 21, 2026) |
| Weeks tracked | 42 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BLISOVI FE 1.5-30 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BLISOVI FE 1.5-30 TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1382 per EA (NDC 68180086913), effective Aug 19, 2026.
How has the price of BLISOVI FE 1.5-30 TABLET changed over time?
Over the history we have for it, the NADAC for BLISOVI FE 1.5-30 TABLET has declined 12.3%. It has been tracked across 42 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for BLISOVI FE 1.5-30 TABLET?
Since Nov 5, 2025, the NADAC for BLISOVI FE 1.5-30 TABLET has ranged from a low of $0.1303 (Feb 18, 2026) to a high of $0.1575 (Nov 12, 2025), with a median of $0.1412 per EA.
Are there cheaper alternatives to BLISOVI FE 1.5-30 TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BLISOVI FE 1-20 TABLET, is $0.1309 per EA — about 5% below BLISOVI FE 1.5-30 TABLET.
Who manufactures BLISOVI FE 1.5-30 TABLET?
BLISOVI FE 1.5-30 TABLET (NDC 68180086913) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.